Evidence map›Paper›PMID 26740322›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2016

Comprehensive real-time epidemiological data from respiratory infections in Finland between 2010 and 2014 obtained from an automated and multianalyte mariPOC® respiratory pathogen test.

M Gunell, P Antikainen, N Porjo, K Irjala, J Vakkila, K Hotakainen, S S Kaukoranta, J J Hirvonen, K Saha, R Manninen and 5 more

Abstract readHistorical ArticleMulticenter Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Human Parvoviruses.Clinical microbiology reviews · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

M GunellMedical Microbiology and Immunology Unit, University of Turku, Kiinamyllynkatu 13, 20520, Turku, Finland. marianne.gunell@utu.fi.
P AntikainenArcDia International Oy Ltd, Turku, Finland.
N PorjoArcDia International Oy Ltd, Turku, Finland.
K IrjalaMehiläinen Private Health Care Center, Espoo, Helsinki, Oulu, Tampere, and Turku, Finland.
J VakkilaMehiläinen Private Health Care Center, Espoo, Helsinki, Oulu, Tampere, and Turku, Finland.
K HotakainenMehiläinen Private Health Care Center, Espoo, Helsinki, Oulu, Tampere, and Turku, Finland.
S S KaukorantaVaasa Central Hospital, Vaasa, Finland.
J J HirvonenVaasa Central Hospital, Vaasa, Finland.
K SahaSeinäjoki Central Hospital, Seinäjoki, Finland.
R ManninenSataDiag, Satakunta Central Hospital, Pori, Finland.
B ForsblomCarea, Kymenlaakso Social and Health Services, Kotka, Finland.
K Rantakokko-JalavaTYKS-Sapa, Microbiology and Genetics Service Area, Microbiology Branch, Turku University Hospital, Turku, Finland.
V PeltolaDepartment of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
J O KoskinenArcDia International Oy Ltd, Turku, Finland.
P HuovinenMedical Microbiology and Immunology Unit, University of Turku, Kiinamyllynkatu 13, 20520, Turku, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory viruses cause seasonal epidemics every year. Several respiratory pathogens are circulating simultaneously and typical symptoms of different respiratory infections are alike, meaning it is challenging to identify and diagnose different respiratory pathogens based on symptoms alone. mariPOC® is an automated, multianalyte antigen test which allows the rapid detection of nine respiratory infection pathogens [influenza A and B viruses, respiratory syncytial virus (RSV), human metapneumovirus, adenovirus, parainfluenza 1-3 viruses and pneumococci] from a single nasopharyngeal swab or aspirate samples, and, in addition, can be linked to laboratory information systems. During the study period from November 2010 to June 2014, a total of 22,485 multianalyte respi tests were performed in the 14 participating laboratories in Finland and, in total, 6897 positive analyte results were recorded. Of the tested samples, 25 % were positive for one respiratory pathogen, with RSV (9.8 %) and influenza A virus (7.2 %) being the most common findings, and 0.65 % of the samples were multivirus-positive. Only small geographical variations in seasonal epidemics occurred. Our results show that the mariPOC® multianalyte respi test allows simultaneous detection of several respiratory pathogens in real time. The results are reliable and give the clinician a picture of the current epidemiological situation, thus minimising guesswork.

Indexed as

Antigens, ViralFinlandGeographyHistory, 21st CenturyHumansImmunoassayRespiratory Tract InfectionsSensitivity and SpecificityVirus DiseasesAntigens, Viral

Identifiers

PMID26740322
PMCPMC7088327

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.